Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
NCT ID: NCT01805817
Last Updated: 2020-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Copper IUD does not have any hormonal molecule inside.
* Hypothesis is OC has more systemic beneficial or side effects than LNG\_IUS or copper IUD. LNG\_IUS has more local effects than copper IUD.
* Study reflects the beneficial or side effects of estrogen+progestagen pills and only progestogen inside device.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
NCT01590537
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
NCT00185380
HR-QoL and Sexuality in Mirena Inserted Contraception Users
NCT00498784
Evaluation of the Effects of Levonorgestrel-releasing Intrauterine Device and Dydrogestreone on Quality of Life and Sexual Life in Patients With Abnormal Uterine Bleeding.
NCT05474703
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Levonorgestrel releasing intrauterine device, contraception
LNG-IUS - Mirena ®,20μgr, once intrauterine insertion per 5 year, 1 year
YASMIN® (Drospirenone/Ethinyl Estradiol)
oral contraceptive pills
The Copper-T is an intrauterine device (IUD)
intrauterine device for contraception
levonorgestrel-releasing system
intrauterine device
YASMIN® (Drospirenone/Ethinyl Estradiol), contraception
oral, once a day, 1 year
YASMIN® (Drospirenone/Ethinyl Estradiol)
oral contraceptive pills
The Copper-T is an intrauterine device (IUD)
intrauterine device for contraception
levonorgestrel-releasing system
intrauterine device
Copper T 380 A , contraception
intrauterine device, once per 10 year, 1 year period
YASMIN® (Drospirenone/Ethinyl Estradiol)
oral contraceptive pills
The Copper-T is an intrauterine device (IUD)
intrauterine device for contraception
levonorgestrel-releasing system
intrauterine device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
YASMIN® (Drospirenone/Ethinyl Estradiol)
oral contraceptive pills
The Copper-T is an intrauterine device (IUD)
intrauterine device for contraception
levonorgestrel-releasing system
intrauterine device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cihangir Uzunçakmak
Medical Doctor, OB/GYN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Haliloglu B, Celik A, Ilter E, Bozkurt S, Ozekici U. Comparison of uterine artery blood flow with levonorgestrel intrauterine system and copper intrauterine device. Contraception. 2011 Jun;83(6):578-81. doi: 10.1016/j.contraception.2010.09.001. Epub 2010 Oct 18.
Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet. 2011 Feb;112(2):126-30. doi: 10.1016/j.ijgo.2010.08.009. Epub 2010 Nov 19.
Mansour D, Gemzell-Danielsson K, Inki P, Jensen JT. Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception. 2011 Nov;84(5):465-77. doi: 10.1016/j.contraception.2011.04.002. Epub 2011 Jun 8.
Related Links
Access external resources that provide additional context or updates about the study.
database for medical publication
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cuzuncakmak1907
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.